Literature DB >> 9052657

The management of hypertrophic cardiomyopathy.

P Spirito1, C E Seidman, W J McKenna, B J Maron.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9052657     DOI： 10.1056/NEJM199703133361107

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  149 in total

1.  Covert video surveillance: an important investigative tool or a breach of trust?

Authors:  N Shabde; A W Craft
Journal:  Arch Dis Child       Date:  1999-10       Impact factor: 3.791

2.  Cardiac causes for syncope or sudden death in childhood.

Authors:  C Wren
Journal:  Arch Dis Child       Date:  1999-10       Impact factor: 3.791

Review 3.  Impact of recent molecular studies on evaluation of ventricular arrhythmias.

Authors:  D M Roden
Journal:  J Interv Card Electrophysiol       Date:  2000-01       Impact factor: 1.900

Review 4.  Current status of alcohol septal ablation for patients with hypertrophic cardiomyopathy.

Authors:  H Seggewiss
Journal:  Curr Cardiol Rep       Date:  2001-03       Impact factor: 2.931

Review 5.  Cardiomyopathy: The diagnosis of hypertrophic cardiomyopathy.

Authors:  E D Wigle
Journal:  Heart       Date:  2001-12       Impact factor: 5.994

Review 6.  The molecular basis of cardiac arrhythmias.

Authors:  Kalyanam Shivkumar; Narayana S Murali; Subramaniam C Krishnan
Journal:  J Nucl Cardiol       Date:  2002 Mar-Apr       Impact factor: 5.952

Review 7.  Medical treatment of hypertrophic cardiomyopathy.

Authors:  M V Sherrid; D Gunsburg; A Sharma
Journal:  Curr Cardiol Rep       Date:  2000-03       Impact factor: 2.931

Review 8.  Analysis of dual-chamber pacing as a treatment for refractory limiting symptoms in patients with obstructive hypertrophic cardiomyopathy.

Authors:  B J Maron
Journal:  Curr Cardiol Rep       Date:  2000-03       Impact factor: 2.931

9.  The effects of candesartan on left ventricular hypertrophy and function in nonobstructive hypertrophic cardiomyopathy: a pilot, randomized study.

Authors:  Martin Penicka; Pavel Gregor; Roman Kerekes; Dan Marek; Karol Curila; Jiri Krupicka
Journal:  J Mol Diagn       Date:  2008-12-12       Impact factor: 5.568

10.  Cardiac myosin binding protein-C phosphorylation in a {beta}-myosin heavy chain background.

Authors:  Sakthivel Sadayappan; James Gulick; Raisa Klevitsky; John N Lorenz; Michelle Sargent; Jeffery D Molkentin; Jeffrey Robbins
Journal:  Circulation       Date:  2009-02-23       Impact factor: 29.690
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.